1356009-37-4 Usage
Appearance
Yellow crystalline solid The compound has a yellow color and a crystalline structure, which is a common feature in many organic compounds.
Molecular weight
242.25 g/mol The molecular weight of the compound is the sum of the atomic weights of all the atoms in the molecular formula, which is 242.25 grams per mole.
Usage in synthesis
Pharmaceutical and agrochemical products 2-(4-aminobutoxy)-4-nitrobenzonitrile is used as a building block in the creation of various pharmaceuticals and agrochemicals, which can have a wide range of applications, such as treating diseases or protecting crops.
Intermediate in organic synthesis
The compound can be used as an intermediate in organic synthesis, meaning it can be further modified or react with other chemicals to produce a desired final product.
Chemical structure
Benzene ring with a nitro group, a nitrile group, and an aminobutoxy side chain The compound's structure consists of a benzene ring, which is a six-carbon ring with alternating single and double bonds. Attached to the benzene ring are a nitro group (-NO2), a nitrile group (-C≡N), and an aminobutoxy side chain (-NH2-(CH2)3-O-).
Potential applications
Development of new drugs and organic compounds Due to its unique structure and reactivity, 2-(4-aminobutoxy)-4-nitrobenzonitrile has potential applications in the development of new drugs and organic compounds, which could lead to the discovery of novel therapeutic agents or other useful materials.
Check Digit Verification of cas no
The CAS Registry Mumber 1356009-37-4 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,5,6,0,0 and 9 respectively; the second part has 2 digits, 3 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1356009-37:
(9*1)+(8*3)+(7*5)+(6*6)+(5*0)+(4*0)+(3*9)+(2*3)+(1*7)=144
144 % 10 = 4
So 1356009-37-4 is a valid CAS Registry Number.
1356009-37-4Relevant articles and documents
COMPOUNDS FOR THE REDUCTION OF BETA-AMYLOID PRODUCTION
-
Page/Page column 59, (2012/02/02)
Compounds of the formula (I) are provided, including pharmaceutically acceptable salts thereof: which modulate β-amyloid peptide (β-AP) production, and are useful in the treatment of Alzheimer's Disease and other conditions affected by -amyloid peptide (β-AP) production.
